UBE-CEL
Dead / Abandoned — Abandoned — failure to respond (as of 06 Jul 2023)
What this means for you
This application is over — abandoned 23 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97275694
- Mark type
- Stylized text
- Filed
- 20 Feb 2022
- Abandoned
- 23 Jun 2023
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for the treatment of Angelman Syndrome; Gene therapy products for the treatment of Angelman Syndrome, namely, genetically engineered genes for the production of proteins
Owner
- Transformatx Biotherapeutics LLC, Lexington, MA, US
Prosecution history
- 06 Jul 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 06 Jul 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 06 Jul 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Mar 2023 — NON-FINAL ACTION E-MAILED
- 22 Mar 2023 — NON-FINAL ACTION WRITTEN
- 06 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Dec 2022 — NON-FINAL ACTION E-MAILED
- 06 Dec 2022 — NON-FINAL ACTION WRITTEN
- 05 Dec 2022 — ASSIGNED TO EXAMINER
- 24 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Feb 2022 — NEW APPLICATION ENTERED